HALOZYME THERAPEUTICS, INC. Annual Operating Income (Loss) in USD from 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Halozyme Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
  • Halozyme Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was $176M, a 73.7% increase year-over-year.
  • Halozyme Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was $551M, a 63.4% increase year-over-year.
  • Halozyme Therapeutics, Inc. annual Operating Income (Loss) for 2024 was $551M, a 63.4% increase from 2023.
  • Halozyme Therapeutics, Inc. annual Operating Income (Loss) for 2023 was $338M, a 26.2% increase from 2022.
  • Halozyme Therapeutics, Inc. annual Operating Income (Loss) for 2022 was $268M, a 3.03% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $551M +$214M +63.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-18
2023 $338M +$70M +26.2% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-18
2022 $268M -$8.37M -3.03% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-18
2021 $276M +$132M +91.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $144M +$212M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 -$67.6M +$1.72M +2.48% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-22
2018 -$69.3M -$150M -186% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 $81M +$164M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 -$83.2M -$55.8M -203% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-21
2015 -$27.5M +$35.6M +56.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-20
2014 -$63M +$17.4M +21.6% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 -$80.4M -$26.8M -50% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 -$53.6M -$33.8M -170% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
2011 -$19.8M +$34.4M +63.4% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-28
2010 -$54.3M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.